304 related articles for article (PubMed ID: 14742958)
1. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
[TBL] [Abstract][Full Text] [Related]
2. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.
Videtic GM; Gaspar LE; Zamorano L; Stitt LW; Fontanesi J; Levin KJ
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):963-8. PubMed ID: 11704318
[TBL] [Abstract][Full Text] [Related]
3. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas.
Videtic GM; Gaspar LE; Zamorano L; Fontanesi J; Levin KJ; Kupsky WJ; Tekyi-Mensah S
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):687-92. PubMed ID: 10524423
[TBL] [Abstract][Full Text] [Related]
4. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
Gutin PH; Prados MD; Phillips TL; Wara WM; Larson DA; Leibel SA; Sneed PK; Levin VA; Weaver KA; Silver P
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):601-6. PubMed ID: 1651302
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
6. Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas.
Schwartz C; Romagna A; Thon N; Niyazi M; Watson J; Belka C; Tonn JC; Kreth FW; Nachbichler SB
Acta Neurochir (Wien); 2015 Oct; 157(10):1757-64; discussion 1764. PubMed ID: 26298594
[TBL] [Abstract][Full Text] [Related]
7. High activity iodine-125 interstitial implant for gliomas.
Scharfen CO; Sneed PK; Wara WM; Larson DA; Phillips TL; Prados MD; Weaver KA; Malec M; Acord P; Lamborn KR
Int J Radiat Oncol Biol Phys; 1992; 24(4):583-91. PubMed ID: 1429079
[TBL] [Abstract][Full Text] [Related]
8. Brachytherapy: Results of two different therapy strategies for patients with primary glioblastoma multiforme.
Koot RW; Maarouf M; Hulshof MC; Voges J; Treuer H; Koedooder C; Sturm V; Bosch DA
Cancer; 2000 Jun; 88(12):2796-802. PubMed ID: 10870063
[TBL] [Abstract][Full Text] [Related]
9. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
Gabayan AJ; Green SB; Sanan A; Jenrette J; Schultz C; Papagikos M; Tatter SP; Patel A; Amin P; Lustig R; Bastin KT; Watson G; Burri S; Stea B
Neurosurgery; 2006 Apr; 58(4):701-9; discussion 701-9. PubMed ID: 16575334
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
11. Permanent I-125 brain stem implants in children.
Chuba PJ; Zamarano L; Hamre M; Bhambhani K; Canady A; Guys MB; Matter A; Portillo G; Chung-bin S; Fontanesi J
Childs Nerv Syst; 1998 Oct; 14(10):570-7. PubMed ID: 9840381
[TBL] [Abstract][Full Text] [Related]
12. Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases.
Kickingereder P; Hamisch C; Suchorska B; Galldiks N; Visser-Vandewalle V; Goldbrunner R; Kocher M; Treuer H; Voges J; Ruge MI
J Neurooncol; 2014 Dec; 120(3):615-23. PubMed ID: 25151509
[TBL] [Abstract][Full Text] [Related]
13. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
14. Interstitial brachytherapy procedures for brain tumors.
Sneed PK; McDermott MW; Gutin PH
Semin Surg Oncol; 1997; 13(3):157-66. PubMed ID: 9143053
[TBL] [Abstract][Full Text] [Related]
15. Interstitial radiosurgery of low-grade gliomas.
Kreth FW; Faist M; Warnke PC; Rossner R; Volk B; Ostertag CB
J Neurosurg; 1995 Mar; 82(3):418-29. PubMed ID: 7861220
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.
Ruge MI; Kickingereder P; Grau S; Dorn F; Galldiks N; Treuer H; Sturm V
Neuro Oncol; 2013 Dec; 15(12):1721-31. PubMed ID: 24046261
[TBL] [Abstract][Full Text] [Related]
17. Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.
Patel S; Breneman JC; Warnick RE; Albright RE; Tobler WD; van Loveren HR; Tew JM
Neurosurgery; 2000 May; 46(5):1123-8; discussion 1128-30. PubMed ID: 10807244
[TBL] [Abstract][Full Text] [Related]
18. Permanent 125iodine implants for recurrent malignant gliomas.
Gaspar LE; Zamorano LJ; Shamsa F; Fontanesi J; Ezzell GE; Yakar DA
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):977-82. PubMed ID: 10192343
[TBL] [Abstract][Full Text] [Related]
19. Permanent iodine-125 implants in the up-front treatment of malignant gliomas.
Fernandez PM; Zamorano L; Yakar D; Gaspar L; Warmelink C
Neurosurgery; 1995 Mar; 36(3):467-73. PubMed ID: 7753345
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]